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Transportation of Nanoscale Cargoes by Myosin
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1 School of Natural Sciences, Linnaeus University, Kalmar, Sweden, 2 Biochemistry Department, University of Groningen, Groningen, The Netherlands
Abstract
Myosin II propelled actin filaments move ten times faster than kinesin driven microtubules and are thus attractive
candidates as cargo-transporting shuttles in motor driven lab-on-a-chip devices. In addition, actomyosin-based
transportation of nanoparticles is useful in various fundamental studies. However, it is poorly understood how actomyosin
function is affected by different number of nanoscale cargoes, by cargo size, and by the mode of cargo-attachment to the
actin filament. This is studied here using biotin/fluorophores, streptavidin, streptavidin-coated quantum dots, and
liposomes as model cargoes attached to monomers along the actin filaments (‘‘side-attached’’) or to the trailing filament
end via the plus end capping protein CapZ. Long-distance transportation (.100 mm) could be seen for all cargoes
independently of attachment mode but the fraction of motile filaments decreased with increasing number of side-attached
cargoes, a reduction that occurred within a range of 10–50 streptavidin molecules, 1–10 quantum dots or with just 1
liposome. However, as observed by monitoring these motile filaments with the attached cargo, the velocity was little
affected. This also applied for end-attached cargoes where the attachment was mediated by CapZ. The results with side-
attached cargoes argue against certain models for chemomechanical energy transduction in actomyosin and give important
insights of relevance for effective exploitation of actomyosin-based cargo-transportation in molecular diagnostics and other
nanotechnological applications. The attachment of quantum dots via CapZ, without appreciable modulation of actomyosin
function, is useful in fundamental studies as exemplified here by tracking with nanometer accuracy.
Citation: Persson M, Gullberg M, Tolf C, Lindberg AM, Ma˚nsson A, et al. (2013) Transportation of Nanoscale Cargoes by Myosin Propelled Actin Filaments. PLoS
ONE 8(2): e55931. doi:10.1371/journal.pone.0055931
Editor: Laurent Kreplak, Dalhousie University, Canada
Received October 18, 2012; Accepted January 3, 2013; Published February 21, 2013
Copyright:  2013 Persson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Carl Trygger Foundation, the European Union Seventh Framework Programme (FP7/2007–2011) under grant agreement
number 228971 (MONAD), the Swedish Research Council (Project #621-2007-6137 and #621-210-5146), the Faculty of Natural Sciences and Engineering at
Linnaeus University and the Netherlands Organisation for Scientific Research (NWO-VIDI Grant 700.57.427 to AK). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have read the journal’s policy and have the following conflicts: Alf Ma˚nsson is a co-founder, co-owner and CEO of the start-
up company ActoSense Biotech AB (Kalmar, Sweden) aiming to develop diagnostic devices based on the aggregation of cytoskeletal elements, particularly actin
filaments, in solution. Moreover, A Ma˚nsson holds two Swedish patents in this field and application for one of these patents (about aggregation of actin filaments
by analyte molecules) has also been filed in the US and Europe. A. Swedish patent 1: Ma˚nsson A, Ta˚gerud S, Sundberg M, Rosengren JP, Montelius L, Omling P,
Bunk R, Nicholls IA and Balaz M. (2007) Arrangemang fo¨r en miniatyriserad separation av kemiska substanser (analyter) och/eller en testning av kemiska
substansers effekt pa˚ molekylmotorers funktioner. Swedish Patent SE 528 700 B. Swedish patent 2: Ma˚nsson, A and Ta˚gerud, S. (2008). Ka¨nslig detektion av gifter,
patogener och sjukdomsmarko¨rer genom aggregation av cytoskeletala filament. Swedish Patent SE 531 135. B1. European patent application based on Sw. patent
2: Detection conjugate. Application number: EP20070852077 B2. US patent application based on Sw. patent 2: Detection conjugate. Application number: 12/
517,148; Publication number: US 2010/0248212 A1 This does not alter the authors9 adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: alf.mansson@lnu.se (AM); a.kocer@rug.nl (AK)
¤ Current address: National Veterinary Institute, Technical University of Denmark, Lindholm, Kalvehave, Denmark
Introduction
Intracellular transport of nanoscale cargoes (lipid vesicles,
mitochondria etc.) is executed by molecular motors [1,2] such as
kinesins and dyneins, walking along tracks of microtubules and
myosins walking along actin filaments. This has inspired develop-
ment of molecular motor driven lab-on-a-chip devices [3,4,5,6,7]
with cargo pick-up and transportation [8,9,10,11,12,13,14,15,
16,17]. Possible applications include periodic chemistry [18,19],
assembly of molecular components [20,21,22], sorting, positioning
and/or concentration [20,23,24,25,26,27] of molecules. Even proof-
of-principle diagnostics devices [28,29,30,31,32] have been de-
scribed, with significant future potential [3,7]. In the mentioned
applications, cargo-transportation usually relies on surface immobi-
lization of the motors with microtubules and actin filaments as
‘‘shuttles’’ with attached cargoes of nanometer (e.g. oligonucleotides,
proteins or nanoparticles) to micrometer size (e.g. polystyrene beads,
bacteria or large liposomes) [10,12,13,14,21,22,29,33,34,35,36,37,
38,39,40,41]. In a vast majority of these studies the microtubule-
kinesin motor system has been employed, partly due to the belief that
effective cargo-transportation is considerably more challenging with
actomyosin [7,11,42,43], e.g. related to possible rotation of the
filaments around their long axis [44,45]. Such rotation may be
deleterious if bulky cargoes are attached to the actin monomers along
the filament length (‘‘side-attached’’). Accordingly, in several recent
studies the cargoes have been attached either to bundled actin
filaments [15,37] (with increased complexity) or to the trailing end
(‘‘end-attached) of the filament via the capping protein gelsolin
[10,33,40].Even thoughthe latterapproachwouldalleviate rotation-
induced clashes with a dense motor layer, the small capacity for cargo
loading would be a limitation in nanotechnological applications. On
the other hand, the attachment to the trailing end may be useful for
fundamental studies, e.g. labelling of the filament plus end [46],
tracking with nanometer accuracy [47,48] and application of loads to
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the actin filaments via magnetic particles [10]. However, in this case it
is important toensure that thecappingprotein itselfdoesnotaffect the
actomyosin function, a possibility with gelsolin [49] since actin
filament structure is modified by interactions of gelsolin with the actin
monomer at the filament end [50,51,52,53].
In view of the ten-fold higher speed of actomyosin driven
transportation compared to microtubule-kinesin driven transpor-
tation and the perceived [7] difficulties in using actin filaments as
shuttles, it is of interest to define the maximum capacity of cargo
transportation with side-attached cargoes of different size for
effective use in various nanodevices. Based on limited evidence in
the literature [11,32,37], we hypothesize that the capacity is high
for protein-sized cargoes, but quite small for slightly larger cargoes
(e.g. quantum dots), due to rotation of the filament around its long
axis during sliding. We also hypothesize that any steric clashes due
to rotation would be eliminated if the nanoparticles were attached
to the trailing end of actin filaments via a suitable capping protein.
Particularly, we postulate that CapZ, not previously tested for this
purpose, would be suitable. Thus, unlike the capping protein
gelsolin, CapZ does not sever actin filaments suggesting that
structural changes in the filaments are more limited.
In order to address the above hypotheses, we here study
actomyosin-based transportation of side-attached and end-at-
tached model cargoes, including streptavidin, quantum dots and
liposomes, of sizes comparable to diagnostically relevant antibod-
ies, viruses and microvesicles, respectively (Fig. S1). Furthermore,
we show, for the first time, transportation of cargoes attached to
the trailing end of actin filament via the plus end actin capping
protein CapZ [54,55,56]. The results with side-attached cargoes
show that .1000 covalently immobilized biotins, .50 streptavidin
molecules, .4 quantum dots and liposomes may be transported at
similar velocity as in the absence of cargo. However, the fraction of
motile filaments was reduced with increased degree of cargo
loading. Whereas only limited effect was seen for up to 50
streptavidin molecules, quite severe effects were observed for just a
few quantum dots or single liposomes. The results with end-
attached cargoes suggest that CapZ does not cause noticeable
effect on motility. The results are discussed in relation to future
development of actomyosin-powered nanodevices and the use of
nanoparticle-attachment in fundamental studies. Key results that
shed new light on important mechanisms of actomyosin based
motion generation are also discussed.
Materials and Methods
Ethics Statement
All experiments using animal material were approved by the
Regional Ethical Committee for Animal experiments in Linko¨p-
ing, Sweden (reference numbers: 52–05, 58–08 and 96–11) and
performed in accordance with national and EU legislations.
Abbreviations
A list of abbreviations (Abbreviations S1) is given in the
Supporting Information.
Solutions and Chemicals
Actin monomers (G-actin) were dissolved in G-buffer: 2 mM
tris-HCl pH 7.6, 0.2 mM adenosine-59-triphosphate (ATP),
0.2 mM CaCl2, 0.2 mM Ditiothreitol (DTT) and 0.2 mM
NaN3. Heavy meromyosin (HMM) and other proteins were
diluted in a buffer A: 10 mM 3-morpholinopropane-1-sulfonic
acid (pH 7.4), 1 mM MgCl2, 0.1 mM ethylene glycol tetraacetic
acid, 1–10 mM DTT and appropriate amounts of KCl to produce
ionic strengths in the range 40–130 mM. All chemicals were of
analytical grade and, if not otherwise stated, purchased from
Merck (Darmstadt, Germany), Sigma-Aldrich (St. Louis, MO,
USA) or Fluka and Riedel-de Hae¨n (Seelze, Germany). Alexa
FluorH 488 phalloidin (APh), rhodamine phalloidin (RhPh) and
QdotH 605 Streptavidin conjugate (quantum dot) were all
purchased from Invitrogen - Molecular Probes (Eugene, OR,
USA) while tetramethylrhodamine-isothiocyanate (TRITC)-strep-
tavidin was purchased from Pierce (Rockford, IL, USA).
Protein Preparations
Actin and myosin II were isolated from rabbit back muscle and
rabbit fast leg muscle [57]. Myosin was digested by a-chymotryp-
sin to prepare HMM [58], whereas actin was purified essentially as
in [59] with special care taken to remove tropomyosin, troponins
and other soluble proteins. The G-actin was stored on ice and used
within a week. Alternatively, G-actin or actin filaments (F-actin)
were frozen in liquid nitrogen and stored at 280uC until use (cf.
[60]).
CapZ was expressed in Escherichia coli (E. coli) and purified as
described previously [54]. Briefly, the expression was induced with
0.1 mM isopropyl b-D-thiogalactopyranoside for 3 h before lysis
of cells and purification on a HisTrapTM HP column (GE
Healthcare Bio-Science AB, Uppsala, Sweden) according to
manufacturers protocol. The purity of the actin and CapZ
preparations are illustrated by the sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) in Fig. S2.
Protein Biotinylation and Covalent Rhodamine Labelling
Actin and CapZ were biotinylated with N-Hydroxysulfosucci-
nimide (NHS) ester coupling chemistry using an EZ-Link Sulfo-
NHS-LC-Biotinylation kit (Pierce) according to manufacturers
protocol (see also [61]). Alternatively, CapZ was labelled with
rhodamine using a NHS-Rhodamine antibody labelling kit
(Pierce) according to manufacturer’s protocol resulting in 1–2
rhodamines per CapZ molecule. The extent of biotinylation
according to 49-hydroxyazobenzene-2-carboxylic acid assay was
0.8–1 biotins per actin monomer (unless otherwise stated) and 4–6
biotins per CapZ molecule. In the experiments using fluorescent
TRITC-streptavidin there were 4 biotins per actin monomer and
2 TRITC molecules, on average, per streptavidin.
Biotinylated Liposome Preparation
All lipids were purchased from Avanti Polar Lipids Inc.
Alabaster, Alabama. Liposomes were prepared from 1,2-Diphy-
tanoyl-sn-Glycero-3-Phosphocholine, 1-Palmitoyl-2-Oleoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)], cholesterol and 1,2-distear-
oyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene
glycol)-2000] (ammonium salt) with a ratio 70:25:5:1 wt. % as
explained before [62]. Briefly, lipids from chloroform stocks were
mixed at the desired weight ratio and a thin lipid film was obtained
by evaporating the chloroform in a rotary evaporator. The lipid
film was rehydrated at 50uC for 45 min by adding 1 ml buffer
(10 mM Tris, pH 7.5). After 5 freeze and thaw cycles in liquid
nitrogen and 50uC water-bath, respectively, the liposomes were
stored at 280uC for further use. Before experiments, pre-warmed
liposomes (10 mg/ml) were extruded 11 times through a 400 nm
pore size polycarbonate filter (Avestin) and the resulting large
unilamellar vesicles were titrated at 50uC with AnapoeH-X-100
(Triton X-100) until saturation. The detergent-destabilized lipo-
somes were mixed with 1 volume of 200 mM calcein (Na-salt)
(Sigma). Detergent removal was achieved by incubating the
mixture with 200 mg wet weight of Bio-Beads SM-2 adsorbents
(Bio-Rad Laboratories, Hercules, CA, USA) at 4uC. This
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procedure yields biotinylated unilamellar liposomes (average
diameter of 100 nm) with 100 mM fluorescent calcein inside [63].
In vitro Motility Assay – General Aspects
All dilutions of proteins and washing steps were performed using
buffer A with ionic strength of 60–80 mM unless otherwise stated.
In vitro motility assays were performed according to standard
methods [42,58,61], where 50–120 mg/ml rabbit HMM was first
adsorbed to cover glasses derivatized with trimethylchlorosilane
(TMCS, Sigma; [43,64]). Subsequently, the in vitro motility assay
flow cell was incubated with 1 mg/ml biotin-free bovine serum
albumin fraction V (BSA; Sigma-Aldrich) for 30 s – 1 min. In
some experiments, ATP insensitive ‘‘rigor heads’’ of HMM were
either removed by affinity precipitation using ultracentrifugation
in the presence of F-actin and ATP [65] or by incubating 1 mM
non-fluorescent ‘‘blocking actin’’ directly in the flow cell before
introducing fluorescent/biotinylated F-actin (2–10 nM; monomer
concentration). F-actin was labelled with RhPh or APh as in [58].
All assay solutions contained 1 mM MgATP (unless otherwise
stated), had pH 7.4 and were supplemented with an oxygen
scavenger system (3 mg/ml glucose, 100 mg/ml glucose oxidase,
20 mg/ml catalase, 10 mM DTT). The ionic strength was either
40 (A40), 60 (A60), 80 (A80), 90 (AMc90) or 130 mM (AMc 130)
as adjusted with KCl. In the AMc90 and AMc130 assay solutions,
0.5–0.6% methylcellulose (M0262, Sigma-Aldrich; 2% aqueous
solution gives viscosity 400cP) was included to prevent filaments
from diffusing away from the surface. The motility assays were
generally performed at room temperature (21–23uC) but the
temperature was in some experiments, increased to 25 or 29uC.
The range of temperatures used, gave sliding velocities in the
range of 2 to 10 mm/s. Importantly, the temperature was constant
within 60.5uC during each given experiment.
Samples were observed using an inverted epifluorescence
microscope (Eclipse TE 300, Nikon, Tokyo, Japan) equipped with
an oil immersion objective (100x, NA 1.40, Nikon). Alternatively,
an objective based total internal reflection fluorescence (TIRF)
microscope was used. This was built around the microscope using
a TIRF objective (60x, NA 1.49, Nikon) and a 532 nm diode laser
for illumination. Actin filaments that were labelled with RhPh,
TRITC-streptavidin or quantum dot were visualized using a
TRITC filter-set (Ex. 540/25, DM 565, BA 605/55). APh-labelled
actin filaments or calcein loaded liposomes were visualised by a
fluorescein isothiocyanate (FITC) filter-set (Ex. 465–495, DM 505,
BA 515–555). Images were acquired using an electron multiplying
charge coupled device (EMCCD) camera (C9100-12, Hamamatsu
Corporation, Hamamatsu, Japan). The sequence of images was
captured at ,5 s21. The sliding velocities were estimated from
these image sequences using a manual version of a previously
described tracking program [66,67]. In this software, an algorithm
searches for the 10 frames in a row, where the coefficient of
variation (CV) of the frame-to-frame velocity is lowest (cf. Fig. S3).
If not otherwise stated, the velocity data below refer to the mean
value for several filaments of such 10-frame averages with CV
,0.5. Another measure of velocity, the average velocity (Fig. S3A),
was obtained by dividing the distance moved with the time
(generally in the range of 5–20 s) over which the movement took
place. Here, all moving (but not entirely stationary) filaments were
included in the analysis whether they moved smoothly or not.
When different conditions (e.g. different number of quantum dots
per filament) were compared, similar time (number of image
frames) was used for all conditions. For velocity-length plots, actin
filament lengths were obtained from filament intensity as described
previously [42].
In vitro Motility Assay with Nanoscale Cargoes Attached
along Actin Filaments
TRITC-streptavidin (1–100 nM) or streptavidin coated quan-
tum dots (2–10 nM) were incubated for 1 min in flow cells with
biotinylated actin filaments attached to HMM. The flow cell was
washed before the motility was initiated by addition of the different
assay solutions (A40, A80, or AMc130). For experiments in which
free biotin in solution was used to block the unoccupied biotin-
binding sites of streptavidin, the flow cell was washed with 20 nM–
40 mM biotin before the motility was initiated by addition of
AMc130. This gave at least 8 times higher concentration of free
biotin than the incubated streptavidin concentration.
For liposome attachment, RhPh labelled and biotinylated F-
actin was first immobilised on HMM before incubation with non-
fluorescent streptavidin (24 nM) for 1 min. Subsequently, two
rinsing steps were imposed before calcein filled liposomes were
added to the flow cell. Finally, the flow cell was further washed two
times before the motility was initiated by infusing AMc130
solution.
In vitro Motility Assay with Nanoscale Cargoes Attached
to the Trailing End of Actin Filaments
Actin filaments capped with CapZ were obtained by having
either biotinylated or rhodamine labelled CapZ present during
polymerization of G-actin to F-actin for 3 h. The polymerization
was initiated by addition of KCl, MgCl2 and ATP to the final
concentrations 100 mM, 2 mM and 3.3 mM, respectively, in G-
actin buffer and APh was added at equimolar concentrations to
achieve fluorescence labelling. The filaments were used the same
day in the in vitro motility assay. When using filaments with
biotinylated CapZ, quantum dots (1–10 nM) were incubated in
the flow cell for 30 s – 1 min. Subsequently, the flow cell was
washed before the motility was initiated by addition of the different
assay solutions (A60, AMc90 or AMc130). For the nanometer
tracking experiments, AMc130 solution was used with MgATP
concentrations ranging from 0 to 50 mM.
Number of Fluorescent Streptavidin Molecules Per mm of
an Actin Filament
The number of TRITC-streptavidin molecules along an actin
filament was calculated from the background-subtracted fluores-
cence intensity on the assumption of 2 TRITC-molecules per
streptavidin (according to manufacturers specification). The
intensity attributed to each TRITC-molecule was obtained from
the fluorescence intensity per RhPh in RhPh labelled F-actin with
the assumptions of 1.360 RhPh molecules/ mm and 2. the same
fluorescence intensity per RhPh as per TRITC molecule on
streptavidin. The validity of these assumptions is supported by a
recent analysis [32].
Tracking with nm Accuracy
Quantum dots attached to the trailing end of actin filaments via
CapZ were tracked by fitting a two-dimensional Gaussian function
[47] to the diffraction limited intensity distribution of the quantum
dot. The image frames in these experiments were captured using
an EMCCD chip (C9100-12, Hamamatsu; see above) with a pixel
size corresponding to 1656165 nm2 on the flow cell using a
1006objective (NA 1.4). The frame rate was 5 frames/s. Repeated
measurements using stationary quantum dots suggested a tracking
accuracy of 65 nm (standard deviation).
Actin Filaments as Molecular Shuttles
PLOS ONE | www.plosone.org 3 February 2013 | Volume 8 | Issue 2 | e55931
Data Analysis
Data are expressed as mean 6 standard error of the mean
(SEM) or as mean 695% confidence interval (CI) as indicated.
Linear and non-linear regression and other statistical analyses
were performed using GraphPad Prism software (version 5.01,
GraphPad Software, San Diego, CA, USA).
Results
Negligible Effects on Motility of more than Thousand
Small Molecules and Tens of Streptavidin Molecules
Per mm of an Actin Filament
The approximately 360 actin monomers per mm of an actin
filament [68,69], each with reactive lysines and cysteines, serve
as regularly spaced and naturally occurring sites for covalent
modification [32], e.g. biotinylation. Thus, in order to attach
streptavidin-labelled cargoes to F-actin, the filaments were first
covalently biotinylated with 1–4 biotins per actin monomer
(,360–1500 per mm of the filament). In these and other
experiments in the present study, the biotins were attached to
lysines on actin and both biotinylation and subsequently
streptavidin binding would be most likely for the most accessible
lysines in the order: (i). Lys-113, (ii) Lys 215 and (iii) Lys-50,
Lys-191, Lys-284, Lys-291, Lys-315, Lys-326 and Lys-359
(Analysis using Swiss-Pdb Viewer 4.0.44 http://www.exapzy.
org/spdbv/ of Protein data bank entry 1M8Q). This biotinyla-
tion (Fig. 1, Table 1) had, in itself, negligible effects on the
HMM induced actin sliding velocity and on the fraction of
motile filaments whether pre-incubation with blocking actin (to
block rigor-like heads) was employed or not. Moreover (Table 1),
actin filaments exhibited similar sliding velocities (cf. [60]) and
fractions of motile filaments whether they were labelled with
APh or RhPh. To study the interaction between biotinylated
actin filaments and fluorescent streptavidin (,5 nm in diame-
ter), biotinylated actin filaments (4 biotins per actin) were first
immobilized to HMM on the surface before incubation with 1–
100 nM TRITC-streptavidin. This caused appreciable concen-
tration dependent (Fig. 1A, B) streptavidin labelling (5–60
streptavidin molecules/ mm). In addition, there was non-specific
binding of TRITC-streptavidin to the HMM coated surface
(Fig. 1 A–B) even if BSA had been used to block non-specific
binding. In the absence of free biotin in the solution (e.g.
Fig. 1A; Movie S1) there was increased tendency for blocking of
the motility by inter- and intrafilament cross-linking via biotin-
streptavidin-biotin links. This was particularly seen at low
streptavidin loading of the filaments with a large number of free
biotin molecules accessible on actin. An observation worth
noting in this connection, is the self-assembly of actin filament
spools (insets Fig. 1A, Movie S1; see previous microtubule
results [70]) stabilized by intrafilament biotin-streptavidin
mediated cross-links particularly seen with low streptavidin
loading on actin. Addition of biotin to the streptavidin labelled
filaments under these conditions reduced the actin filament
cross-linking via streptavidin-biotin links (Fig. 1A, C). A similar
effect of biotin was not observed at high streptavidin loading
(Fig. 1B, C; Movie S2).
The sliding velocity during periods of smooth sliding (CV of
frame-to-frame velocity ,0.5) was only negligibly affected by
binding of 1–60 streptavidins/ mm (Fig. 1D). In contrast, the
average velocity (including periods with temporarily halted
motility) was reduced with increased number of streptavidin
molecules in one of the two separate experiments (Fig. 1E). This is
consistent with the increased fraction of stationary filaments,
which, however, was observed in both experiments (Fig. 1C).
Side-attached Quantum Dots have Minimal Effects on
Sliding Velocity
Next, we studied the effect of larger cargoes by attachment of
streptavidin coated semiconductor quantum dots to the filaments.
The quantum dots had 5–10 streptavidin molecules immobilized
on the surface and exhibited smaller and large axes diameters of
15 and 20 nm, respectively (manufacturers specifications). The
approximate diameters in the absence of streptavidin were 5 and
12 nm, respectively. In a first set of experiments, biotinylated actin
filaments were incubated for ,2 min with streptavidin coated
quantum dots (2 nM) while immobilised to HMM in the in vitro
motility assay flow cell. This led to binding of mostly one, but
occasionally two quantum dots to between 3 and 15% of the
filaments in 6 different experiments (mean 7.561.7%; Movie S3).
A similar total number of non-specifically bound quantum dots
were observed on the flow cell surface outside the biotinylated
filaments. The sliding velocity was not appreciably affected by the
quantum dot attachment whether pre-incubation with blocking
actin (non-fluorescent actin filaments to block dead heads) was
employed or not (Table 1, last row). Moreover, in great contrast
with previous studies using quantum dot-attachment to actin
filaments via biotin-phalloidin, we observed events with long-
distance transportation (.100 mm; Fig. S3) at ionic strengths up to
80 mM in the absence of viscosity enhancing methylcellulose.
The effects of quantum dot loading on HMM induced actin
filament sliding at varying ionic strengths are illustrated in Fig. 2
for experiments distinct from those in Table 1 (and at higher
temperatures than these). In accordance with data in Table 1, the
fraction of motile filaments (Fig. 2A) tended to be reduced,
whereas the velocity (Fig. 2B) was minimally affected by quantum
dot attachment at all ionic strengths tested.
In another set of experiments, biotinylated actin filaments were
incubated with quantum dots under conditions resulting in 1 to
.5 quantum dots per filament and also to the formation of cross-
linked filament aggregates (Fig. 3A, Movie S4). It can be seen in
Fig. 3B that the fraction of motile filaments decreased with an
increased number of quantum dots in the range 1–4, whereas
there was negligible effect on sliding velocity (Fig. 3C). This lack of
effect on velocity remained during up to 10 min observation
period (Fig. S4A).
Motility (sometimes good) was also observed for larger number
of quantum dots, but in these instances (cf. Fig. 3A, Movie S4) it
was usually difficult to count the exact number of quantum dots or
clarify to what degree the filaments were aggregated via quantum
dot-streptavidin-biotin bonds. Therefore, no quantitative estimates
of motility quality were obtained for .4 quantum dots per
filament. Neither did we attempt detailed studies of the
concentration dependence of the degree of quantum dot binding
to the actin filaments. The short incubation times and rather low
quantum dot concentrations used here were chosen to limit the
degree of non-specific binding outside the filaments. The
limitation on actin binding in this case was not saturation of
binding sites but rather the slow diffusion of the comparatively
large quantum dots to the binding sites on actin [71].
In some random instances, two parts of a filament (e.g. leading
and trailing; Fig. S5) were loaded with several quantum dots,
whereas the remaining part(s) of the filament was unlabelled.
Filaments of this type moved over large distances without
appreciable tendencies for stops and pauses. For instance, the
filament in Fig. S5 that initially had 4–5 quantum dots at each end
(2 in front end detached after about 10 mm of sliding), moved for
..100 mm at an average velocity of 1.72 mm/s compared to
1.7360.096 mm/s (n = 18 filaments) in the absence of quantum
dots in the same flow cell.
Actin Filaments as Molecular Shuttles
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An additional observation of interest was that one filament
with two quantum dots executed nearly continuous counter-
clockwise rotation for 164 s, apparently with one of the actin-
attached quantum dots as an axis. Altogether, 30 full rotations
in the same direction were observed. Similar behaviour is
observed for one filament in Movie S4 (in the lower right,
second half of the movie).
Liposomes can be Transported at High Sliding Velocity
Streptavidin-mediated attachment of biotinylated liposomes
(diameter .,50 nm) along actin filaments had greater effect on
HMM induced sliding than quantum dot attachment. In this case,
a reduced fraction of motile filaments (Fig. 4A) with increased
number of attached liposomes was associated with slightly reduced
velocity (Fig. 4B; Movie S5). Large liposomes (.100 nm in
diameter) occasionally caused filament detachment from the
Figure 1. Effect of different degrees of streptavidin labelling on HMM induced actin filament motility. A. Biotinylated and APh labelled
F-actin (5 nM), immobilized to HMM on a surface, then incubated with 1 nM TRITC-streptavidin for 1 min followed by rinsing and incubation by
AMc130 assay solution. Observation using TRITC filter set. Arrow indicates motile TRITC-streptavidin labelled filament. Other filament-like objects
represent cross-linked and non-motile filaments. Inset: nanospool of actin filament formed by intra-filament biotin-streptavidin cross-linking. Left
image, TRITC-filter set to observe TRITC-streptavidin. Right image, FITC-filter set to observe Alexa-488-labelling of the same filament. B. Same
conditions as in A except for incubation with 20 nM TRITC-streptavidin and 40 mM biotin in solution. Arrows indicate motile filaments. Note, brighter
background than in A, presumably due to non-specific binding of TRITC-streptavidin. C. Fraction of motile filaments vs. average number of
streptavidin molecules per mm filament length. Vertical error bars: SEM. Horizontal error bars: standard deviation. D. Velocity for filaments with
different number of streptavidin molecules measured during the periods of smoothest sliding (CV ,0.5). E. Average velocity during 6–16 s plotted
against number of streptavidin molecules per filament length. Black and grey symbols: two different experimental dates with different HMM, actin
and streptavidin batches. Red symbols: covalently biotinylated F-actin with addition of 0–20 nM TRITC-streptavidin followed by 20 nM to 40 mM
biotin, prior to motility assay. Same experimental date as black. Straight full lines obtained by linear regression as well as dashed lines representing
95% confidence intervals.
doi:10.1371/journal.pone.0055931.g001
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surface. The average velocity of filaments with one attached
liposome did not change appreciably over a 10 min period as
tested in one experiment (Fig. S4B). Most actin filaments in the
experiments with liposomes presumably had several more
streptavidin molecules attached than those required to link the
liposome to the filament, possibly contributing to lower fraction of
motile filaments (see above).
In some experiments, we observed large liposomes (as suggested
by high fluorescence intensity; Movie S6) that appeared to roll on
the surface with a velocity similar to that for filaments without
liposomes. The actin filaments in such experiments, observed by
switching to a TRITC filter-set, appeared as ellipsoids or spheres
with greater width than other filaments in the image (Movie S6). A
possible interpretation is that one actin filament was bent around
the liposome in a way that the bend and two ends of the filament
are not fully resolved in the microscope. Indeed, the actual
formation of such a bend was directly observed in one case.
Alternatively, in other cases two or more actin filaments may have
attached on the liposome. This is similar to a strategy systemat-
ically exploited for liposome transportation in a recent study [41].
CapZ is an Alternative to Gelsolin for Attaching Cargos to
the Plus End of Actin Filaments
Here, we describe the first in vitro motility assay study using actin
filaments with CapZ attached to the actin filament plus end
(according to search on PubMed September 22, 2012). Poly-
histidine tagged CapZ was expressed in E. coli [54] and purified
(Fig. S2), as described previously [54,55]. For our experiments,
CapZ was either biotinylated or labelled with rhodamine, using
NHS-ester based conjugation chemistry. Both the a- and b
subunits of the CapZ heterodimer were labelled by these
procedures as suggested by fluorescence following gel electropho-
resis (rhodamine) or estimation of molar mass by SDS-PAGE. This
labelling procedure did not inhibit the actin capping capability
(Fig. S6) and allowed production of CapZ capped actin filaments
by polymerisation in the presence of CapZ. Quantum dots
(incubation with 1–10 nM for 30 s - 1 min) were attached to the
biotinylated CapZ after immobilization of the capped actin
filaments on a HMM coated surface. Considering the effects of
CapZ on actin filament length (Fig. S6), it is reasonable to presume
that a majority of the filaments are capped with CapZ. The fact
that ,5% of the filaments bound quantum dots is most likely
attributed to slow diffusion during a limited incubation period.
This is in accordance with the low quantum dot binding along
biotinylated actin filaments (see above). After quantum dot
binding, an ATP-containing assay solution was added to observe
motility (Movie S7). It can be seen in Fig. 5A–B (from overlapping
95% confidence intervals) that CapZ attachment was without
consistent effect on HMM propelled actin filament velocity. This
was tested and found to apply within the range of ionic strengths
where a noticeable effect of gelsolin was seen in a recent study
[49]. For practical reasons these results were obtained at rather
low temperature (room temperature , 22uC). However, in a
control experiment the effect of CapZ was also studied at higher
temperature (, 29uC, Fig. 5C). Neither in this case did the
presence of CapZ significantly affect the sliding velocity provided
that correction was performed for the fact that the filaments with
CapZ were shorter. This is important because length per se, affects
velocity (see [72] and Fig. S7). In the in vitro motility assay
experiments with CapZ, the presence of the capping protein was
either verified by the attachment of streptavidin coated quantum
Table 1. Effect of covalent biotinylation and quantum dot attachment on HMM induced actin sliding.
Velocity (mean ± SEM; mm/s)1/fraction of motile filaments
Sample With blocking actin Without blocking actin
Actin- RhPh 2.0260.09 (n = 20)/80% motile 2.0660.04 (33)/71% motile
Actin-APh 2.0160.1 (24)/73% motile 2.1460.07 (23)/75% motile
Biotin-actin-RhPh 1.9760.07 (96)/83% motile 1.9360.04 (37)/75% motile
Biotin-actin-APh 1.9060.07 (51)/77% motile 1.7760.1 (26)/77% motile
Biotin-actin-APh +1 quantum dot 1.9560.09 (17)/41% motile 1.8460.08 (52)/66% motile
1A80 solution. No methylcellulose in assay solution. Motility assay performed at room temperature (21–23uC) and kept constant within 60.5uC during each experiment.
Number of filaments used for velocity measurements in parentheses. RhPh: rhodamin-phalloidin; APh: AlexaFluorH 488 phalloidin.
doi:10.1371/journal.pone.0055931.t001
Figure 2. Motility quality for biotinylated actin filaments with
1–2 quantum dot cargoes attached along the filaments. A.
Fraction of motile filaments in the absence (black) and presence (grey)
of quantum dots. Error bars represent SEM. B. Sliding velocity for
biotinylated F-actin without (black) and with (grey) quantum dots. Error
bars represent 95% confidence intervals. Number of filaments given in
parentheses.
doi:10.1371/journal.pone.0055931.g002
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dots to biotinylated CapZ or by covalent rhodamine labelling. The
fraction of motile filaments was not appreciably affected by the
presence of CapZ and the fraction of motile filaments was higher
than 50% for actin filaments that had quantum dots attached via
CapZ.
The fact that CapZ did not affect the sliding velocity suggests
that it should be useful to mediate attachment of quantum dots or
magnetic particles [10] in fundamental studies of actomyosin
function. Here, we exemplify this potential usefulness by
demonstrating tracking with nanometer accuracy [47] of quantum
dots attached to CapZ on HMM propelled actin filaments (Fig.
S8). This allowed us to obtain accurate MgATP-velocity
information at low MgATP concentration with frame rates as
high as 5 s21 (Fig. 5D). Thus, the plot of velocity against [MgATP]
is nearly linear in the range of 5–30 mM MgATP and extrapolates
to zero as expected for a hyperbolic relationship between velocity
and MgATP-concentration [67,73]. The non-zero velocity at
[MgATP] = 0 mM reflects the approximately 5 nm uncertainty in
each position estimate used for the velocity calculation. This is,
however, considerably less than the uncertainty in the centroid
tracking method [66]. As also shown in Fig. 5D, this centroid
tracking method gives an apparent velocity of approximately
0.5 mm/s at 0 mM MgATP and also considerably higher velocities




The fraction of motile filaments, the velocity of smoothly sliding
filaments (CV,0.5),) and the average velocity report different
aspects of actomyosin function. The ‘‘smooth’’ velocity character-
izes the optimal function under the condition studied. The average
velocity, on the other hand, reports the velocity that would be most
representative for the behaviour of an ensemble of moving
filaments, e.g. in a nanodevice. Thus, in this case filaments were
not selected based on the smoothness of sliding – all filaments were
included even those that were stationary for all or a very small
fraction of the measurement period. Importantly, the filaments
moved for appreciably longer times and distances than generally
used for velocity measurements (Fig. S3 and Fig. S4) and there was
no substantial change in motility (velocity and fraction of motile
filaments) over the periods (usually around 5 minutes) when
measurements were made. This should be compared to less than 1
minute required for actomyosin driven concentration on a
nanostructured surface [74]. Additionally, as the velocities did
not change with time, measurements over short time periods for a
large number of randomly selected filaments would be just as
Figure 3. Motility quality vs. number of attached quantum dots
on HMM propelled filaments. A. Fluorescence micrograph time
series at 3 s intervals showing several motile and some non-motile and
heavily quantum dot labelled actin filaments. All fluorescence in the
micrographs is attributed to the quantum dots. The colour coded
arrows point to some motile filaments/aggregates with 5 quantum dots
(blue arrow; apparently single filament), .5 quantum dots and
presumably 2 cross-linked filaments (orange arrow), small aggregate
(white arrow), large aggregate (red arrow). B. The average fraction of
motile filaments in 3 different experiments. Error bars: SEM (n = 3
different flow cells and experimental occasions for different number of
quantum dots; .3–11 quantum dot-labelled filaments per flow cell).
The solid line (included for descriptive purpose) represents a single
exponential function decaying with increased number of quantum dots
to a plateau value. Optimal parameter values and 95% confidence
interval (dotted lines) obtained by non-linear regression analysis. C. The
mean sliding velocity 695% confidence intervals in 3 (or 4; for 1–3
quantum dots) different experiments. The filled symbols and solid line
represent the ten frames running average of the frame-to-frame
velocities with lowest CV on the condition that CV,0.5. The open
symbols and dashed line, on the other hand, represents average
velocities calculated by dividing the integrated sliding distance with the
tracking duration (11–14 s; shorter in the few cases when filaments
moved out of the image).
doi:10.1371/journal.pone.0055931.g003
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representative for the average velocity of the filament ensemble as
measurements over more extended time periods.
Relation to Earlier Results
Covalent modification (by NHS-biotin) of up to 4 lysines per
actin monomer affects neither the capability for actin polymeri-
zation nor the actomyosin motor function (see also Kumar et al.
[32]). This brings new possibilities for extensive covalent
modification of the lysines also for other purposes, e.g. attachment
of antibodies at high densities along the actin filament for use in
diagnostics applications [7,31,32]. The success of covalent
biotinylation is also important for certain fundamental studies of
actomyosin function [75,76] because the previously used alterna-
tive actin-phalloidin link [11,60] to couple biotin to actin has a
limited half-life of ,30 min [77]. The present motility assays with
quantum dot attachment to covalently biotinylated actin filaments
could, unlike those with biotin-phalloidin mediated quantum dot-
attachment [11], be performed in the absence of viscosity
enhancing methylcellulose in the assay solution at ionic strengths
up to 80 mM (where actomyosin interactions are rather weak)
without appreciable detachment of the actin filaments. This
considerably improved motility suggests that effective actomyosin
driven cargo-transportation is easier to achieve with side-attached
cargoes than usually believed (cf. [7]). It is unclear whether the
improved motility compared to the previous study [11] is due to
geometrical differences between the two modes of biotinylation or
to recent changes in commercial preparation of the streptavidin
coated quantum dots (not revealed by Invitrogen for proprietary
reasons). In spite of the improved motility compared to previous
work [11], our results are, nevertheless, consistent with findings
[39,51] that substantial cargo-loading of actin filaments with
cargoes having diameters of tens of nanometers would give lower
fraction of motile filaments. Importantly, however, we found only
small effects on motility with small cargoes (of biotin-streptavidin
size), even when the loading was quite extensive. The lower
fraction of motile filaments with liposomes than with quantum dots
supports the view (cf. [37]) that cargo-size is an important factor.
Therefore, with large cargoes, unipolar actin bundles where the
actin filaments are cross-linked via fascin [78], may be more
effective [15,37] as HMM propelled shuttles than isolated actin
filaments despite the increased complexity imposed by bundle
production and need to maintain bundle integrity over time.
The effects of cargoes along actin filaments on actomyosin
motility were generally of the all-or-none type. That is, if motility
was inhibited it was usually completely switched off, at least
temporarily, whereas only limited effects on sliding velocity were
seen for motile filaments. This seems to be different from the
inhibition of motility of microtubules propelled by conventional
kinesin 1, where a substantial reduction in velocity was observed
with increasing streptavidin loading of the filament [29,79]. These
differences may be related to the fact that myosin II, in contrast to
conventional kinesin motors, is non-processive. The processive
motion of kinesin along microtubules would be temporarily
blocked at a cargo ‘‘road-block’’ [29], but the kinesin motor
could overcome the road-block without detaching [29], translating
into a reduction of velocity for an ensemble of kinesins. In contrast,
the detachment of a substantial fraction of active myosin II motors
could lead to temporary or long-term switching off of motility and
even detachment from the surface. The lack of cargo-effects on the
sliding velocity might at first seem surprising, particularly in the
presence of methylcellulose where drag forces might be of
relevance. However, methylcellulose alters the macroscopic
viscosity, but not the microscopic viscocity and therefore does
not inhibit sliding filament velocity [72,80]. Also, a simple
calculation suggests that the drag forces should be very small in
any case. Thus, if a quantum dot is approximated by a sphere, the
drag force (Fdrag) is given by the relationship Fdrag = 6pgrvf,where
r is the quantum dot radius, vf is the sliding velocity and g is the
viscosity (,150 cP for the type and concentration of methylcel-
lulose used here) [72]. Now, inserting r,10 nm and vf,10 mm/s
it follows that the viscous drag force on a quantum dot is less than
0.3 pN, i.e. considerably lower than the average force per myosin
head of several pN [81]. In addition, at the HMM surface
densities, ATP concentrations and velocities used here there are on
the order of 10 myosin heads attached per mm of the filament at
each given time [42]. Under these conditions the drag force would
also be negligible for liposomes with radius five times higher than
for a quantum dot.
More on Cargo Transportation with Side-attached
Cargoes
In contrast to the lack of effects of covalent biotinylation, an
increased fraction of stationary filaments and temporary stops in
the sliding was observed upon increasing streptavidin, quantum
Figure 4. Motility quality vs. number of attached liposomes on HMM propelled filaments. A. The fraction of motile filaments at two
different experimental dates (black and grey). B. The sliding velocity. Velocity data represented by black and grey represent two different
experiments. The filled symbol and solid line represent velocities obtained from the ten frames running average of the frame-to-frame velocities with
lowest CV (CV,0.5), while the open symbols and dashed line represents the average velocity as described in Fig. 3. The numbers in parentheses
represent the number of filaments studied for each condition (.10 in B unless otherwise stated). Error bars: SEM. Temperature: 21uC.
doi:10.1371/journal.pone.0055931.g004
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dot and liposome loading. Only small effects were seen with up
to ,50 streptavidins per mm of the actin filament. However, the
effect was noticeably enhanced with increased cargo size and for
a given number of cargoes. Thus the fraction of motile
filaments progressively decreased from streptavidin over quan-
tum dots to liposomes. This was the case in spite of a
streptavidin layer on both the quantum dots and the liposomes.
The inhibiting effects of the cargoes may be attributed to
different forms of non-specific interactions with HMM
[43,82,83] and/or the prevention of myosin binding to actin.
However, the HMM-quantum dot interactions seem to be
weaker than interactions between quantum dots and the
underlying TMCS-surface. Thus, increased non-specific surface
binding of quantum dots was observed at low HMM incubation
concentrations (in spite of the presence of BSA) or when myosin
subfragment 1 was used as a motor fragment instead of HMM
(unpublished observations). However, extensive interactions
between quantum dots attached to actin filaments and the
TMCS-surface are unlikely at the high HMM incubation
concentrations (50–120 mg/ml) used here. This is attributed to
high HMM surface density [42,43,84] that would be expected
to block access to the surface (cf. [83]). Additionally, quantum
dots attached to actin filaments are more than 20 nm away
from the surface due to the thickness of the HMM layer. This
further limits the probability for direct surface interactions [43].
Finally, interactions with non-fluorescent blocking actin fila-
ments [42] seem to be without relevance because omission of
blocking actin did not appreciably modify the quantum dot
effects on motility.
Different possibilities to account for the temporary stops and a
larger fraction of stationary filaments in the presence of cargoes
may be considered. First, bulky cargoes as well as a large number
of small cargoes may block access of HMM to binding sites on
actin, consistent with a tendency for filaments loaded with large
pieces of cargo to temporarily detach from active HMM
molecules. This effect may be alleviated by annealing actin
filament fragments with and without cargoes to produce contin-
uous cargo-free stretches (cf. [12,39]) as indicated in Fig. S5. Non-
specific interactions between cargoes and the underlying HMM
coated surface most likely contribute to motility inhibition. The
non-specific interactions may include steric trapping of cargoes in
spaces between HMM molecules. The idea of such trapping,
without rigid surface attachment of the quantum dots, is consistent
Figure 5. Effect of CapZ binding to F-actin on HMM propelled
actin filament velocity. A. Sliding velocities at different ionic
strengths for F-actin with (grey) and without (black) CapZ/quantum
dot complex (n = 3 experimental occasions and different HMM
preparations unless indicated in figure; .17 filaments analysed for
each condition). Temperature: 22uC. Inset: two subsequent images
(interval: 1.6 s) of HMM propelled RhPh-labelled F-actin (sliding to the
right) with quantum dot attached to the trailing end via CapZ. B. Sliding
velocities for F-actin capped with CapZ-rhodamine (dashed line, open
symbols), CapZ/quantum dot complex (grey) and without CapZ (black)
in one given experiment (number of filaments in parentheses). C.
Effects of CapZ on sliding velocity at high temperature (28.6uC) in
AMc130 assay solution. Average sliding velocities for F-actin in the
absence of CapZ or in the precence of CapZ/quantum dot complex.
Filament lengths of F-actin without CapZ limited to the mean length of
CapZ capped actin filaments 62 standard deviations (0–3 mm; see
further Fig. S6, Fig. S7) to ensure comparability. Error bars in A–C: 95%
CI. D. Velocity measurements (5 frames s21) at low [MgATP] using
nanometer tracking of quantum dots attached to CapZ (grey) or
tracking the filament centroid (black) for the same filament (number of
filaments in parentheses). Note appreciable overestimation of velocity
at low [MgATP] by centroid tracking due to noise [66] as most clearly
indicated by the tracking of stationary filaments. The tracking of
stationary quantum dots using the Gaussian fit (nanometer tracking)
suggests a precision of ,5 nm in each position estimate. This is based
on the apparent speed of stationary quantum dots of 78 nm/s, a frame
rate of 5 s21, the fact that the speed is a scalar quantity in the analysis
and that each distance between frames, used for the velocity
calculations, depends on two position estimates by Gaussian fits.
doi:10.1371/journal.pone.0055931.g005
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with the observation of several sequential rotations in the same
direction of non-sliding actin filaments around actin-attached
quantum dots (see above and Movie S4). Electrostatic interactions
between the negative net charge of streptavidin at pH 7.4 and a
positive electrostatic surface potential in the actin binding region of
HMM [85,86] is unlikely to be of appreciable significance for the
motility inhibition with few quantum dots because numerous
streptavidin molecules were attached to actin filaments with only
minimal effects on motility (cf. [29]). However, other types of non-
specific interactions, e.g. hydrophobic, between the quantum dot
itself and HMM, may be important. Here, it would be of interest
to study how the chemical characteristics of the cargoes affects
actomyosin function as studied recently for kinesin-microtubule
cargo transportation [79].
Cargo-transportation in Relation to Mechanisms of
Motion Generation and Actin Dynamics
A large fraction of filaments with 1–2 quantum dots and
liposomes were observed to slide throughout the observation
period (often .100 mm). Moreover, even rather large (.100 nm
diameter) cargoes and/or several cargoes per filament were
occasionally transported with minimal effects on velocity suggest-
ing that rotation around the filament long axis during sliding is not
of critical importance for chemomechanical energy transduction
(cf. [45] and compare Fig. S1). The maintained high sliding
velocity with heavy streptavidin loading of actin filaments is also
consistent with this idea. This finding also argues against Brownian
motor models [87] that explain actomyosin force generation by
biased diffusion of myosin heads between binding sites with
progressively lower energy on subsequent monomers along the
actin filament. The similar size of streptavidin compared to the
actin monomer and streptavidin labelling of almost 20% of the
monomers would (assuming uniform distribution of streptavidins
along the filament) limit the average number of diffusional steps of
a myosin head along the filament to less than 2 before detachment
at a streptavidin molecule. This is clearly less than proposed
recently for a Brownian motor model [87]. If movement in such a
model would occur along a given protofilament, the maximum
distance before detachment with 2 steps would be about 10 nm,
clearly less than the value of up to 30 nm at low load observed
experimentally by Kitamura et al. [88].
For the use in studies of actomyosin function (e.g. [33]) it is
important that attachment of e.g. fluorescent tags or other cargoes
via plus end capping proteins does not affect actomyosin kinetics.
Such effects may be expected for gelsolin mediated attachment if
the kinetics is critically dependent on the actin filament structure
since this structure is modified by interactions of gelsolin with
subdomains 1 and 3 of the actin monomer [50,51,52,53]. Indeed,
a study [49] using both Ca- and Mg-actin filaments nucleated in
the presence of gelsolin seem to accord with effects of gelsolin on
motility, whereas another study [33] did not detect such effects.
Therefore, more studies are needed to resolve this issue. Further,
the possibility to use fragments of gelsolin [50] or other capping
proteins within the gelsolin family [89,90] may also be considered.
Here we found no effects on motility of CapZ binding to the actin
filament plus end. This is consistent with minimal structural
changes along the actin filament upon CapZ binding, as expected
because CapZ, unlike gelsolin, does not sever the filament. The
usefulness of CapZ mediated attachment of quantum dots to actin
filaments for future detailed functional studies of actomyosin is
exemplified in Fig. 5D.
Cargo-transportation in Diagnostic Nanodevices
For use in diagnostic nanodevices, antibody coated actin
filaments have recently [31,32] been proposed for capturing
analyte molecules from solution for subsequent rapid motor driven
concentration to a detector site on a nanostructured surface. Our
finding that close to 20% of the actin monomers may be loaded
with protein-sized cargoes without appreciable effect on motility is
therefore essential. However, the use of antibody-coated filaments
for capture of analytes would be of significance particularly at low
analyte concentration when the need for signal amplification by
actomyosin mediated concentration at a detector site is crucial.
Under these conditions, very few (e.g. one or two) antibody-
analyte complexes of sizes similar to quantum dots would be
bound to each actin filament. We have demonstrated here that
such limited cargo loading has quite small effects on motility
quality.
Conclusions
We have demonstrated fast actomyosin based cargo transpor-
tation under a range of conditions using side-attached and end-
attached model cargoes with different sizes similar to those of
diagnostically relevant biomarkers and nanoparticles. The results,
together with recent demonstration of long-term storage of
actomyosin based nanodevices [91] guiding of actomyosin motility
along nano-tracks [18] and covalent antibody attachment to actin
filaments [31,32] support the usefulness of actomyosin for
nanoseparation in medical diagnostics devices. The results with
streptavidin loading also have potential implications for mecha-
nistic models of actomyosin based motion generation and the
effect may deserve further investigation. Finally, our results favour
the use of CapZ, rather than gelsolin for mediating attachment of
e.g. quantum dots or magnetic particles to the trailing end of actin
filaments in various fundamental studies.
Supporting Information
Figure S1 Schematic illustration of streptavidin, quan-
tum dots and liposome attachment to F-actin used in
present work. A. Attachment of quantum dot and liposome
along actin filament via biotin-streptavidin links. B. Attachment of
quantum dot via a plus-end binding protein in the form of
biotinylated CapZ. Arrow indicates direction of movement in the
in vitro motility assay. Figure approximately to scale.
(TIF)
Figure S2 SDS-PAGE of CapZ, biotinylated CapZ and
actin. A. NovexH 4–20% gradient tris-glycine acrylamide gel
(Invitrogen) was run under reducing conditions and stained using
NovexH colloidal blue staining kit (Invitrogen). Sample prepara-
tion, running conditions and staining procedure were performed
according to manufacturer’s protocol. Lane 1– Purified CapZ
expressed in Escherichia coli (1 mg, two subunits with 39 and 42 kDa
apparent molecular weights), Lane 2– biotinylated CapZ (1 mg, 4–
6 biotins/CapZ molecule). Lane 3– rabbit skeletal actin (1 mg,
48 kDa apparent molecular weight). Lane 4– Protein standard
SeeBlueH Plus 2 (Invitrogen). The apparent molecular weights in
kDa are indicated on the gel. Lane 5– purity control for CapZ
(10 mg). Lane 6– purity control for biotinylated CapZ (10 mg).
Lane 7–purity control for rabbit skeletal actin (10 mg).
(TIF)
Figure S3 Matlab program output after tracking HMM
propelled F-actin with long-distance transportation of
quantum dot. This quantum dot was attached to biotinylated
actin filament and the assay solution was a80. A. Sliding distance
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plotted against time during 28.2 s tracking period with a total
distance of 120.4 mm. Average velocity, vavg, during this period
calculated as the ratio vavg = 120.4/28.2 mm/s < 4.27 mm/s. B.
Frame-to-frame velocity plotted against frame number (at 0.2 s
interval). C. Filament path in x-y-plane (2506250 pixels;
330 nm2/pixel). D. The running average of ‘‘smoothest’’ sliding
velocity (minimum coefficient of variation; CV) over ten frames
plotted against the number of ten frame windows. E. The
minimum ten-frame CV of the sliding velocity. Note, the mean
velocity in D is updated for each reduction in CV in E to select the
velocity of smoothest sliding. F. Minimum CV and corresponding
mean velocity for 10-frame (CV-10; vmean-10) and 4-frame (CV-
4; vmean-4) running averages from measurements illustrated in A–
E.
(TIF)
Figure S4 Velocity of actin filaments with cargoes does
not change over a 10 min period. A. The velocity of
smoothly sliding (CV,0.5) HMM-propelled actin filaments with 1
to 4 quantum dots in one experiment at different times after onset
of recording. See inset for meaning of symbols. B. The average
velocity (see Materials and Methods) of HMM-propelled actin
filaments with 1 liposome in one experiment at different times
after onset of recording. Each point in A and B refers to a given
filament at the time point considered. Full lines and dashed lines
represent regression line and 95% confidence intervals, respec-
tively, both obtained in linear regression analysis.
(TIF)
Figure S5 Actin filament with 4–5 quantum dots at each
end, sliding downwards in the image. The unlabelled centre
of the filament is surrounded by two straight yellow lines. The time
interval between the two snapshots is 5.2 s.
(TIF)
Figure S6 Effects of CapZ on actin filament length
distribution. Monomeric actin was polymerized for 3 h in the
absence and presence of CapZ/biotinylated CapZ and labelled
with APh. Length measurements were done from images for
HMM immobilized actin filaments in the absence of ATP.
(TIF)
Figure S7 Sliding velocity vs. filament length for actin
filaments without CapZ. The arrow represents the range of
lengths (0–3 mm) covered by approximately 95% of the filaments
with CapZ, measured when these filaments were bound to HMM
in rigor (corresponding to mean 62 standard deviation of the
CapZ actin filament lengths). It is likely that the length was slightly
reduced upon addition of MgATP due to filament fragmentation
caused by motor induced shearing. Thus, the filaments without
CapZ, used for velocity measurements, were only those with
lengths in the range 0–3 mm in order to ensure reasonable
comparability with the velocity of filaments with CapZ/quantum
dots complex. The length of the latter filaments was generally not
measured for practical reasons. Temperature: 28.6uC. HMM
incubation concentration, 120 mg/ml. AMc130 assay solution.
Filament lengths measured from intensity data as described by
Sundberg et al. [42] to account for errors due to filament motion
during exposure time and diffraction limitation for short filaments.
(TIF)
Figure S8 Tracking of quantum dots with nm accuracy.
Intensity profiles (bottom) of stationary quantum dot (bright spots at
top left; 40640 mm2) were fitted by two-dimensional Gaussian
function for each image frame (frame rate 5 s21). Brownian
motion, tracking errors etc. (from tracking in the x-y plane for 1.8 s)
gave a variation in position of less than 10 nm suggesting that
tracking was possible with ,10 nm accuracy.
(TIF)
Movie S1 HMM-propelled actin filaments coated with
streptavidin attached to the filaments via biotinylated
actin. Covalently biotinylated actin filaments (5 nM; monomer
concentration; 4 biotins/actin) were immobilized on HMM in the
flow cell and then incubated with 1 nM TRITC-labelled
streptavidin for 1 min. The actin filaments were also labelled
with Alexa-488 phalloidin. The movie first illustrates the TRITC-
labelled streptavidin using a TRITC filter set followed by
observation of the entire filaments using a FITC filter set
(approximately 7–13 s into movie) and finally, the TRITC-
labelled streptavidin, again. Note that two filaments self-organize
into spools. Main Fig. 1A extracted from movie. Frame rate: 5 s21
(real time) and image size: 85685 mm2.
(MOV)
Movie S2 HMM-propelled actin filaments coated with
streptavidin attached to the filaments via biotinylated
actin. Actin filaments (5 nM; monomer concentration; 4 biotins/
actin) were immobilized on HMM in the flow cell and then
incubated with 20 nM TRITC-labelled streptavidin for 1 min.
The concentration of free biotin to block unoccupied biotin-sites of
streptavidin was 40 mM. The actin filaments were also labelled
with Alexa-488 phalloidin. The movie first illustrates the TRITC-
labelled streptavidin using a TRITC filter set followed by
observation of the entire filaments using a FITC filter set at the
end. Main Fig. 1B extracted from movie. Frame rate: 5 s21 (real
time) and image size: 85685 mm2.
(AVI)
Movie S3 HMM-propelled actin filaments with strepta-
vidin coated quantum dots attached to the filaments via
biotinylated actin. The actin filaments were also labelled with
Alexa-488 phalloidin. The movie first illustrates a few frames with
the FITC filter set to observe the entire filaments whereas the
remaining frames were obtained using the TRITC filter set to
observe the quantum dots with emission maximum at 605 nm.
Filaments and quantum dots pseudocolored to indicate their
different emission maxima. Note, 1. that only a small fraction of
the filaments are labelled with quantum dots and 2. that there is a
substantial number of non-specifically bound quantum dots, falsely
indicating a large number of stationary actin filaments with
quantum dots. From series of experiments in Fig. 2 (a80 solution).
Frame rate: 5 s21 (real time) and image size: 85685 mm2.
(MOV)
Movie S4 HMM-propelled actin filaments with strepta-
vidin coated quantum dots attached to the filaments via
biotinylated actin. The filaments are dually labelled and
observed using a filter that simultaneously allows observation of
Alexa-488 and quantum dots (emission maximum at 605 nm).
Note, large number of quantum dots (.5) attached to,
presumably, two cross-linked filaments at top left (no free biotin
in assay solution). Note further that one filament with two
quantum dots (one at very front) that moves to the right, suddenly
stops and begins to rotate counter-clockwise for five consecutive
turns. This indicates unconstrained rotation around one of the
quantum dots as an axis and continuous driving of this rotation by
appropriately located HMM molecules. From series of experi-
ments in Fig.3 (a80 solution). Frame rate: 5 s21 (real time). Image
size: 46633 mm2.
(MOV)
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Movie S5 HMM-propelled actin filaments with calcein
loaded liposomes attached to the filaments via strepta-
vidin and biotinylated actin. In order to observe the
liposomes the movie was recorded using the FITC filter set. Note,
that not all stationary liposomes represent stationary filaments due
to some non-specific binding of liposomes to the surface. Note
further, 1. single ‘‘small’’ liposomes are rather photobleached, 2.
one large liposome appears to ‘‘roll’’ over the surface (mid, top).
From series of experiments in Fig.4 (A80 solution). Frame rate:
5 s21 (real time) and image size: 85685 mm2.
(MOV)
Movie S6 HMM-propelled actin filaments with calcein
loaded liposomes attached to the filaments via strepta-
vidin and biotinylated actin. The actin filaments were also
labelled with tetramethylrhodamineisothiocyanate (TRITC)-phal-
loidin. Initially the recording was made using a FITC filter
allowing observation of the liposomes. The filter set was then,
approximately in the middle of the movie, switched to a TRITC
filter set to allow observation of the actin filaments. Note, apparent
rolling of liposome over surface. Frame rate: 5 s21 (real time) and
image size: 20625 mm2.
(MOV)
Movie S7 HMM-propelled actin filaments with quan-
tum dots attached to the actin filaments via biotinylated
CapZ at the plus-end. The actin filaments were also labelled
with Alexa-488 phalloidin. The movie first illustrates a few frames
recorded with the TRITC filter set to observe quantum dots. For a
short sequence in the movie the filter set is changed to FITC to
observe the entire filaments whereas the remaining frames were
obtained using the TRITC filter set to observe the quantum dots
again. Note, that only a small fraction of the filaments are labelled
with quantum dots and that a large fraction of the stationary
quantum dots were non-specifically attached to the surface. HMM
incubation concentration 120 mg/ml. From series of experiments
in Fig. 5 (A60 solution). Frame rate: 5 s21 (real time) and image
size: 85685 mm2.
(AVI)
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